BASF supplies innovative specialties to the pharmaceutical industry
New business development teams from the intermediates and inorganics divisions will be representing BASF at the Convention on Pharmaceutical Ingredients (CPhI) exhibition in Frankfurt from October 27 to 29, 2003.
One of the new developments to be shown on the BASF stand (H 832 in hall 8.0) is a process called BASILTM. The BASILTM system cuts the customer's costs by simplifying separation processes. BASILTM stands for Biphasic Acid Scavenging utilizing Ionic Liquids. This system which has been filed for patent application utilizes the qualities of ionic liquids to remove an acid from a reaction mixture by a simple liquid-liquid phase separation process. Another advantage of the system is that it produces no solids that would need to be segregated in a complicated process. What's more, the improved heat transfer associated with a biphasic liquid mixture results in higher yields which allow increased capacities in existing plants. BASILTM's first commercial application is in the manufacture of alkoxyphenylphosphines. BASF currently plans to apply the principle in other processes and market the system to external customers.
Other news from the department business & finance
